TY - JOUR
T1 - Quantifying metamorphopsia with M-CHARTS in patients with idiopathic macular hole
AU - Wada, Iori
AU - Yoshida, Shigeo
AU - Kobayashi, Yoshiyuki
AU - Zhou, Yedi
AU - Ishikawa, Keijiro
AU - Nakao, Shintaro
AU - Hisatomi, Toshio
AU - Ikeda, Yasuhiro
AU - Ishibashi, Tatsuro
AU - Sonoda, Koh Hei
N1 - Publisher Copyright:
© 2017 Wada et al.
PY - 2017/9/20
Y1 - 2017/9/20
N2 - Purpose: The purpose of this study was to determine the degree of metamorphopsia using M-CHARTS™ in patients with idiopathic macular hole before and after pars plana vitrectomy and internal limiting membrane (ILM) peeling. Patients and methods: The records of 22 eyes of 22 patients with a full-thickness macular hole who underwent pars plana vitrectomy and ILM peeling were reviewed. All patients underwent a complete ophthalmic examination including spectral-domain optical coherence tomography (OCT). Horizontal metamorphopsia (MH) and vertical metamorphopsia (MV) scores were determined using M-CHARTS at the same time. The time course of changes in metamorphopsia and the relationship between best-corrected visual acuity (BCVA) and OCT parameters were assessed. Results: Sealing of the macular hole was noted in all eyes after surgery. BCVA improved significantly from 1 month after surgery (P,0.001). The MV score was significantly higher than the MH score before surgery (P,0.05) and improved significantly from 1 month after surgery (P,0.03). The MH score improved significantly at 6 months after surgery (P,0.001). The postoperative MV and MH scores became closer to one another from 1 month after surgery. Moreover, the MV score was higher than the MH score at all postoperative assessments. There was a significant correlation between the MV and MH scores at all follow-up assessments. There was no significant correlation between BCVA and the MV or MH score at any follow-up assessment. Conclusion: The satisfaction of the patients with macular hole after surgery cannot be necessarily measured by BCVA alone, because M-scores were not correlated to BCVA in postoperative evaluation. Therefore, evaluation of the MV and MH scores can be an independent treatment outcome in addition to BCVA.
AB - Purpose: The purpose of this study was to determine the degree of metamorphopsia using M-CHARTS™ in patients with idiopathic macular hole before and after pars plana vitrectomy and internal limiting membrane (ILM) peeling. Patients and methods: The records of 22 eyes of 22 patients with a full-thickness macular hole who underwent pars plana vitrectomy and ILM peeling were reviewed. All patients underwent a complete ophthalmic examination including spectral-domain optical coherence tomography (OCT). Horizontal metamorphopsia (MH) and vertical metamorphopsia (MV) scores were determined using M-CHARTS at the same time. The time course of changes in metamorphopsia and the relationship between best-corrected visual acuity (BCVA) and OCT parameters were assessed. Results: Sealing of the macular hole was noted in all eyes after surgery. BCVA improved significantly from 1 month after surgery (P,0.001). The MV score was significantly higher than the MH score before surgery (P,0.05) and improved significantly from 1 month after surgery (P,0.03). The MH score improved significantly at 6 months after surgery (P,0.001). The postoperative MV and MH scores became closer to one another from 1 month after surgery. Moreover, the MV score was higher than the MH score at all postoperative assessments. There was a significant correlation between the MV and MH scores at all follow-up assessments. There was no significant correlation between BCVA and the MV or MH score at any follow-up assessment. Conclusion: The satisfaction of the patients with macular hole after surgery cannot be necessarily measured by BCVA alone, because M-scores were not correlated to BCVA in postoperative evaluation. Therefore, evaluation of the MV and MH scores can be an independent treatment outcome in addition to BCVA.
UR - http://www.scopus.com/inward/record.url?scp=85030095164&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85030095164&partnerID=8YFLogxK
U2 - 10.2147/OPTH.S144981
DO - 10.2147/OPTH.S144981
M3 - Article
AN - SCOPUS:85030095164
SN - 1177-5467
VL - 11
SP - 1719
EP - 1726
JO - Clinical Ophthalmology
JF - Clinical Ophthalmology
ER -